Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s…
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s…
Weight-loss drug Zepbound faces coverage challenge from CVS Health
Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.…
Patients struggle as compounded GLP-1 access rapidly shrinks
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many…
Is weight loss drug Mounjaro effective? Expert reacts |
The weight loss drug market is booming. After months of anticipation, Eli Lilly’s drug Mounjaro (Tirzepatide) was also…
Novo preparing for early launch of weight-loss drug Wegovy in India
By Rishika Sadam HYDERABAD (Reuters) – Danish drugmaker Novo Nordisk is looking at an early launch of its…